Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

Akaza, Hideyuki; Procopio, Giuseppe; Pripatnanont, Choosak; Facchini, Gaetano; Fava, Sergio; Wheatley, Duncan; Leung, Kwong; Butt, Mohammad; Silva, Alberto; Castillo, Liliana; Karavasilis, Vasilios; Ozatilgan, Ayse; Hitler, Simon; Ecstein-Fraisse, Evelyne; Ozguroglut, MUSTAFA

doi:10.1200/jgo.18.00009

Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

Akaza H., Procopio G., Pripatnanont C., Facchini G., Fava S., Wheatley D., ...Daha Fazla

JOURNAL OF GLOBAL ONCOLOGY, cilt.4, 2018 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 4
Basım Tarihi: 2018
Doi Numarası: 10.1200/jgo.18.00009
Dergi Adı: JOURNAL OF GLOBAL ONCOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Purpose There is a major clinical need to devise an optimal treatment sequence for the multiple therapy options available for patients with metastatic castration-resistant prostate cancer (mCRPC). In the absence of prospective clinical trials, sequencing information can be derived from large, real-world registry studies.